内镜下构建抗反流黏膜屏障治疗GERD:一项初步研究(附视频)
基于猪天然抗反流机制,开发内镜下构建抗反流黏膜瓣阻挡酸反流的新术式ARMV。回顾性分析30例接受ARMV的GERD患者,术后3个月和1年分别有83.3%和88.5%患者停用或减少PPI,GERD问卷及生活质量评分、食管pH监测指标均显著改善。
要点
- ARMV通过释放并重建贲门黏膜形成双层黏膜瓣,与贲门瘢痕共同阻挡反流。
- 30例手术均成功,平均手术时间72.6±20.3分钟,1例术后出血需内镜止血。
- 术后12个月GERD问卷评分从14.0±2.6降至7.7±2.5,生活质量评分从48.7±15.0降至10.2±5.9。
核心结论
- 这项初步研究显示ARMV对GERD患者是一种安全、可行且有效的手术。
- 需要进一步的前瞻性对照试验来确认其在各内镜抗反流治疗中的地位。
研究设计与样本
- 回顾性分析2019年至2021年接受抗反流黏膜瓣成形术(ARMV)的30例GERD患者,收集术前术后主观和客观评估数据。
主要发现
- 30例ARMV手术均成功完成,平均手术时间72.6±20.3分钟。
- 1例患者术后出血需内镜止血。
- 平均随访时间28.9±13.9个月。
- 30例中25例(83.3%)在ARMV后3个月、26例中23例(88.5%)在ARMV后1年报告停用或减少质子泵抑制剂治疗。
- GERD问卷评分从ARMV前14.0±2.6降至ARMV后12个月7.7±2.5,GERD健康相关生活质量问卷评分从48.7±15.0降至10.2±5.9(两项比较P均<.0001)。
局限性
- 原文为初步研究(pilot study),需要进一步的前瞻性对照试验来确认ARMV在内镜抗反流治疗中的地位。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Based on the porcine natural antireflux mechanism, we developed a novel endoscopic procedure to build an antireflux mucosal flap to block acid reflux and treat GERD. METHODS: The antireflux mucosal valvuloplasty (ARMV) procedure is performed by releasing and reconstructing three-fourths of the circumference of cardiac mucosa at the lesser curvature side into a double-layer mucosal flap. The mucosal flap works together with cardiac scarring to block reflux. We retrospectively reviewed 30 patients who underwent ARMV from 2019 to 2021. Subjective and objective data evaluating GERD were collected before and after ARMV. RESULTS: All 30 ARMV procedures were performed successfully, with a mean operation time of 72.6 ± 20.3 minutes. One patient had postoperative bleeding that required endoscopic hemostasis. The mean follow-up time was 28.9 ± 13.9 months. Twenty-five of 30 patients (83.3%) and 23 of 26 patients (88.5%) reported discontinuation or reduction in proton pump inhibitor therapy 3 months and 1 year after ARMV, respectively. GERD questionnaire and GERD Health-Related Quality of Life questionnaire scores improved significantly from 14.0 ± 2.6 and 48.7 ± 15.0, respectively, before ARMV to 7.7 ± 2.5 and 10.2 ± 5.9, respectively, 12 months after ARMV (P < .0001 in both comparisons). Eleven patients received 24-hour esophageal pH monitoring before and after ARMV. The mean acid exposure time and DeMeester score dropped from 56.9% ± 23.7% and 167.1 ± 80.1, respectively, before ARMV to 5.5% ± 3.0% and 18.6 ± 11.9, respectively, after ARMV (P < .0001 in both comparisons). CONCLUSIONS: This pilot study showed that ARMV is a safe, feasible, and effective procedure for GERD patients. Further prospective and comparative trials are needed to confirm its role among endoscopic antireflux therapies.
引用
- Lu J, Chen F, Lv X, et al. Endoscopic construction of an antireflux mucosal barrier for the treatment of GERD: a pilot study (with video). Gastrointest Endosc. 2023. PMID: 37660832. doi:10.1016/j.gie.2023.08.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。